Literature DB >> 32877210

Manual and semi-automated delineation of locally advanced rectal cancer subvolumes with diffusion-weighted MRI.

Nathan Hearn1,2,3, William Bugg4, Anthony Chan4, Dinesh Vignarajah1,2, Katelyn Cahill1, Daisy Atwell1,2,3, Jim Lagopoulos3,5, Myo Min1,2,3.   

Abstract

OBJECTIVES: To evaluate interobserver agreement for T2 weighted (T2W) and diffusion-weighted MRI (DW-MRI) contours of locally advanced rectal cancer (LARC); and to evaluate manual and semi-automated delineations of restricted diffusion tumour subvolumes.
METHODS: 20 cases of LARC were reviewed by 2 radiation oncologists and 2 radiologists. Contours of gross tumour volume (GTV) on T2W, DW-MRI and co-registered T2W/DW-MRI were independently delineated and compared using Dice Similarity Coefficient (DSC), mean distance to agreement (MDA) and other metrics of interobserver agreement. Restricted diffusion subvolumes within GTVs were manually delineated and compared to semi-automatically generated contours corresponding to intratumoral apparent diffusion coefficient (ADC) centile values.
RESULTS: Observers were able to delineate subvolumes of restricted diffusion with moderate agreement (DSC 0.666, MDA 1.92 mm). Semi-automated segmentation based on the 40th centile intratumoral ADC value demonstrated moderate average agreement with consensus delineations (DSC 0.581, MDA 2.44 mm), with errors noted in image registration and luminal variation between acquisitions. A small validation set of four cases with optimised planning MRI demonstrated improvement (DSC 0.669, MDA 1.91 mm).
CONCLUSION: Contours based on co-registered T2W and DW-MRI could be used for delineation of biologically relevant tumour subvolumes. Semi-automated delineation based on patient-specific intratumoral ADC thresholds may standardise subvolume delineation if registration between acquisitions is sufficiently accurate. ADVANCES IN KNOWLEDGE: This is the first study to evaluate the feasibility of semi-automated diffusion-based subvolume delineation in LARC. This approach could be applied to dose escalation or 'dose painting' protocols to improve delineation reproducibility.

Entities:  

Mesh:

Year:  2020        PMID: 32877210      PMCID: PMC7548370          DOI: 10.1259/bjr.20200543

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  36 in total

1.  Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation.

Authors:  Simon K Warfield; Kelly H Zou; William M Wells
Journal:  IEEE Trans Med Imaging       Date:  2004-07       Impact factor: 10.048

2.  Contouring of prostate tumors on multiparametric MRI: Evaluation of clinical delineations in a multicenter radiotherapy trial.

Authors:  Marcel A van Schie; Cuong V Dinh; Petra J van Houdt; Floris J Pos; Stijn W T J P Heijmink; Linda G W Kerkmeijer; Alexis N T J Kotte; Raymond Oyen; Karin Haustermans; Uulke A van der Heide
Journal:  Radiother Oncol       Date:  2018-05-03       Impact factor: 6.280

3.  Measuring the similarity of target volume delineations independent of the number of observers.

Authors:  Erik Kouwenhoven; Marina Giezen; Henk Struikmans
Journal:  Phys Med Biol       Date:  2009-04-21       Impact factor: 3.609

Review 4.  Uncertainties in volume delineation in radiation oncology: A systematic review and recommendations for future studies.

Authors:  Shalini K Vinod; Michael G Jameson; Myo Min; Lois C Holloway
Journal:  Radiother Oncol       Date:  2016-10-08       Impact factor: 6.280

5.  A tumour control probability model for radiotherapy of prostate cancer using magnetic resonance imaging-based apparent diffusion coefficient maps.

Authors:  Oscar Casares-Magaz; Uulke A van der Heide; Jarle Rørvik; Peter Steenbergen; Ludvig Paul Muren
Journal:  Radiother Oncol       Date:  2016-03-14       Impact factor: 6.280

6.  MRI visibility of gold fiducial markers for image-guided radiotherapy of rectal cancer.

Authors:  Roy P J van den Ende; Lisanne S Rigter; Ellen M Kerkhof; Els L van Persijn van Meerten; Eva C Rijkmans; Doenja M J Lambregts; Baukelien van Triest; Monique E van Leerdam; Marius Staring; Corrie A M Marijnen; Uulke A van der Heide
Journal:  Radiother Oncol       Date:  2018-12-21       Impact factor: 6.280

Review 7.  Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis.

Authors:  Johannes Peter Maarten Burbach; Annemarie Maria den Harder; Martijn Intven; Marco van Vulpen; Helena Marieke Verkooijen; Onne Reerink
Journal:  Radiother Oncol       Date:  2014-10-01       Impact factor: 6.280

8.  Measuring the apparent diffusion coefficient in primary rectal tumors: is there a benefit in performing histogram analyses?

Authors:  Miriam M van Heeswijk; Doenja M J Lambregts; Monique Maas; Max J Lahaye; Z Ayas; Jos M G M Slenter; Geerard L Beets; Frans C H Bakers; Regina G H Beets-Tan
Journal:  Abdom Radiol (NY)       Date:  2017-06

9.  Does setup on rectal wall improve rectal cancer boost radiotherapy?

Authors:  Jean-Paul J E Kleijnen; Bram van Asselen; Martijn Intven; Johannes P M Burbach; Marielle E P Philippens; Jan J W Lagendijk; Bas W Raaymakers
Journal:  Radiat Oncol       Date:  2018-04-04       Impact factor: 3.481

10.  Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference.

Authors:  Constantinos Zamboglou; Benedikt Thomann; Khodor Koubar; Peter Bronsert; Tobias Krauss; Hans C Rischke; Ilias Sachpazidis; Vanessa Drendel; Nasr Salman; Kathrin Reichel; Cordula A Jilg; Martin Werner; Philipp T Meyer; Michael Bock; Dimos Baltas; Anca L Grosu
Journal:  Radiat Oncol       Date:  2018-05-02       Impact factor: 3.481

View more
  1 in total

1.  Semi-automatic tumor segmentation of rectal cancer based on functional magnetic resonance imaging.

Authors:  Franziska Knuth; Aurora R Groendahl; René M Winter; Turid Torheim; Anne Negård; Stein Harald Holmedal; Kine Mari Bakke; Sebastian Meltzer; Cecilia M Futsæther; Kathrine R Redalen
Journal:  Phys Imaging Radiat Oncol       Date:  2022-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.